Back to search
Heparin-induced Thrombocytopenia (HIT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heparin-induced Thrombocytopenia (HIT) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Heparin-induced Thrombocytopenia (HIT) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The investigators would like to analyze platelet/leukoplak activation, quantify and morphologically characterize these aggregates using in vitro analysis, direc…
The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to hepa…
Platelets are essential blood elements to maintain hemostasis. Quantitative or qualitative defects can be responsible of hemorrhagic (platelet disorders) or thr…
The purpose of this study is to collect data on the clinical management of Argatroban in patients with suspected or confirmed heparin-induced thrombocytopenia T…